EXHIBIT 5.1
| | | | | | |
| | +44 20 7418 1300 davispolk.com | | Davis Polk & Wardwell LondonLLP 5 Aldermanbury Square London EC2V 7HR | | |
OPINION OF DAVIS POLK & WARDWELL LONDON LLP
November 23, 2021
Forbion European Acquisition Corp.
4001 Kennett Pike, Suite 302
Wilmington, Delaware 19807
United States of America
Ladies and Gentlemen:
Forbion European Acquisition Corp., a Cayman Islands exempted company (the “Company”), has filed with the Securities and Exchange Commission a Registration Statement on Form S-1 (the “Registration Statement”) and the related prospectus (the “Prospectus”) for the purpose of registering under the Securities Act of 1933, as amended (the “Securities Act”), 11,500,000 units of the Company (the “Units”), including 1,500,000 Units subject to the Underwriters’ (as defined below) over-allotment option, as described in the Registration Statement. Each Unit consists of:
| (i) | one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Shares”) for an aggregate of up to 11,500,000 (including up to 1,500,000 Shares included in the Units subject to the Underwriters’ over-allotment option); and |
| (ii) | one-third of one warrant (collectively, the “Warrants”), with each Warrant entitling the holder to purchase one Share, for an aggregate of up to 3,833,333 Warrants (including up to 500,000 Warrants included in the Units subject to the Underwriters’ over-allotment option) to be issued under a warrant agreement (the “Warrant Agreement”) to be entered into by the Company and Continental Stock Transfer & Trust Company, as Warrant Agent (the “Warrant Agent”), |
offered pursuant to the terms of an underwriting agreement (the “Underwriting Agreement”) to be executed by the Company and UBS Securities LLC and Kempen & Co. USA, Inc., as representatives of the underwriters named therein (the “Underwriters”). To the extent that there are no additional Underwriters named in the Underwriting Agreement other than UBS Securities LLC and Kempen & Co. USA, Inc., the term representatives as used herein shall mean UBS Securities LLC and Kempen & Co. USA, Inc., as Underwriters.
We, as your counsel, have examined originals or copies of such documents, corporate records, certificates of public officials and other instruments as we have deemed necessary or advisable for the purpose of rendering this opinion.
In rendering the opinions expressed herein, we have, without independent inquiry or investigation, assumed that (i) all documents submitted to us as originals are authentic and complete, (ii) all documents submitted to us as copies conform to authentic, complete originals, (iii) all documents filed as exhibits to the Registration Statement that have not been executed will conform to the forms thereof, (iv) all signatures on all documents that we reviewed are genuine, (v) all natural persons executing documents had and have the legal capacity to do so, (vi) all statements in certificates of public officials and officers of the Company that we reviewed were and are accurate and (vii) all representations made by the Company as to matters of fact in the documents that we reviewed were and are accurate.
Davis Polk & Wardwell London LLP is a limited liability partnership formed under the laws of the State of New York, USA and is authorised and regulated by the Solicitors Regulation Authority with registration number 566321.
Davis Polk includes Davis Polk & Wardwell LLP and its associated entities